Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
World game at war: why some European nations have threatened a World Cup boycott 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
The delay is not the result of any matters concerning the Company’s continuing operations, but is caused by the reporting processes necessary to satisfy the requirement to reflect the discontinuation of its specialty pharmacy operations.
MEMPHIS, Tenn., April 17, 2018 -- Fred's, Inc. (NASDAQ:FRED) has rescheduled its conference call to discuss its financial results for the fourth quarter and fiscal year ended February 3, 2018.
The conference call originally scheduled for April 18, 2018 will now be held on Friday, May 4, 2018 at 8:00 a.m. Eastern time. The delay is related to the decision to sell the Company’s specialty pharmacy business, and is not the result of any matters concerning the Company’s continuing operations.
During the fourth quarter of 2017, the Company’s board of directors approved a plan to actively market the Company’s specialty pharmacy business, which necessitated presenting the results of operations for the specialty pharmacy business as discontinued operations for all periods presented in the Company’s Annual Report on Form 10-K.
Accordingly, the Company requires additional time to complete the accounting and reporting processes necessary to satisfy the requirement to reflect the discontinuation of its specialty pharmacy operations. The Company expects that its Annual Report on 10-K will be filed no later than May 4, 2018, and, therefore, has rescheduled the earnings conference call for that date.
The Company will report its financial results in a press release prior to the call.
Fred’s management will host the conference call, followed by a question and answer period.
Date: Friday, May 4, 2018
Time: 8:00 a.m. Eastern time
Toll-free dial-in number: 1-877-407-4018
International dial-in number: 1-201-689-8471
Conference ID: 13678332
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios at (949) 574-3860.
The conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at investors.fredsinc.com.
A replay of the conference call will be available after 11:00 a.m. Eastern time on the same day through May 18, 2018.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 13678332
Company Contact
Joe Anto
Executive Vice President, Chief Financial Officer
(901) 238-3606
Investor Relations Contact
Cody Slach or Sean McGowan
Liolios Group
(949) 574-3860
[email protected]
